RY · Royal Bank Of Canada · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Royal Bank Of Canada's financial reports and regulated publications, as filed with the market regulator, most recent first.
SEDAR+ filings
Every document the issuer filed on SEDAR+, the Canadian Securities Administrators' filing system, since 2017-01-01, newest first.
| Filed | Document | Filing |
|---|---|---|
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Other | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-11-02 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Report of exempt distribution excluding Schedule 1 of 45-106F1 | Report of exempt distribution (NI 45-106) |
| 2026-10-30 | Report of exempt distribution excluding Schedule 1 of 45-106F1 | Report of exempt distribution (NI 45-106) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Consent letter of issuer's legal counsel | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Other | Shelf prospectus (NI 44-102) |
| 2026-10-30 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
| 2026-10-29 | Pricing supplement (specified derivative) | Shelf prospectus (NI 44-102) |
25749 filings. Checked 2026-11-02 23:20 UTC.
Showing 1–50 of 25,749 filings